Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.3 USD | +2.47% | -5.79% | +51.18% |
May. 15 | Inogen, Inc. Announces Separation of Stanislav Glezer as Executive Vice President, R&D and Chief Medical Officer | CI |
May. 07 | Transcript : Inogen, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Financials (USD)
Sales 2024 * | 323M | Sales 2025 * | 337M | Capitalization | 196M |
---|---|---|---|---|---|
Net income 2024 * | -54M | Net income 2025 * | -49M | EV / Sales 2024 * | 0.36 x |
Net cash position 2024 * | 80M | Net cash position 2025 * | 56.6M | EV / Sales 2025 * | 0.41 x |
P/E ratio 2024 * |
-3.75
x | P/E ratio 2025 * |
-4.3
x | Employees | 834 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.76% |
Latest transcript on Inogen, Inc.
1 day | +2.34% | ||
1 week | -5.79% | ||
1 month | +18.07% | ||
3 months | +18.15% | ||
6 months | +45.10% | ||
Current year | +51.18% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Smith
CEO | Chief Executive Officer | 53 | Nov. 09 |
Human Resources Officer | - | 22-01-31 | |
Gregoire Ramade
PRN | Corporate Officer/Principal | 54 | Oct. 31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin King
BRD | Director/Board Member | 67 | 22-03-21 |
Thomas West
BRD | Director/Board Member | 60 | 23-03-31 |
Heather Rider
BRD | Director/Board Member | 64 | 14-08-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.19% | 25 M€ | -2.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 8.3 | +2.34% | 189,736 |
24-05-30 | 8.11 | +0.12% | 201,667 |
24-05-29 | 8.1 | -5.81% | 163,725 |
24-05-28 | 8.6 | -2.38% | 139,445 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.18% | 196M | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+9.25% | 42.5B | |
+15.97% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- INGN Stock